日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic Discovery and Structure-Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors

新型酶激活共价细胞周期蛋白依赖性激酶抑制剂家族的基因组发现和结构活性探索

Jack R Davison, Michalis Hadjithomas, Stuart P Romeril, Yoon Jong Choi, Keith W Bentley, John B Biggins, Nadia Chacko, M Paola Castaldi, Lawrence K Chan, Jared N Cumming, Thomas D Downes, Eric L Eisenhauer, Fan Fei, Benjamin M Fontaine, Venkatesh Endalur Gopinarayanan, Srishti Gurnani, Audrey Hecht,

Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)

发现 7-甲基-5-(1-{[3-(三氟甲基)苯基]乙酰基}-2,3-二氢-1H-吲哚-5-基)-7H-吡咯并[2,3-d]嘧啶-4-胺 (GSK2606414),一种强效且选择性的蛋白激酶 R (PKR) 样内质网激酶 (PERK) 抑制剂

Jeffrey M Axten, Jesús R Medina, Yanhong Feng, Arthur Shu, Stuart P Romeril, Seth W Grant, William Hoi Hong Li, Dirk A Heerding, Elisabeth Minthorn, Thomas Mencken, Charity Atkins, Qi Liu, Sridhar Rabindran, Rakesh Kumar, Xuan Hong, Aaron Goetz, Thomas Stanley, J David Taylor, Scott D Sigethy, Ginge

Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2

鉴定组蛋白赖氨酸甲基转移酶 EZH2 的强效、选择性、细胞活性抑制剂

Sharad K Verma, Xinrong Tian, Louis V LaFrance, Céline Duquenne, Dominic P Suarez, Kenneth A Newlander, Stuart P Romeril, Joelle L Burgess, Seth W Grant, James A Brackley, Alan P Graves, Daryl A Scherzer, Art Shu, Christine Thompson, Heidi M Ott, Glenn S Van Aller, Carl A Machutta, Elsie Diaz, Yong